{"id":332012,"date":"2026-10-29T12:56:53","date_gmt":"2026-10-29T07:26:53","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=332012"},"modified":"2026-10-29T12:56:53","modified_gmt":"2026-10-29T07:26:53","slug":"why-piramal-pharma-ltd-share-price-52-week-high-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/","title":{"rendered":"Piramal Pharma (PPLPHARMA) Share Price Touches Fresh 52-Week High of Rs 239.40, Trades 2.02% Lower"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/pplpharma\/piramal-pharma-ltd-share-price-today\">Piramal Pharma Ltd. (PPLPHARMA)<\/a> share price reached a fresh 52-week high of Rs 239.4 today and later stood at Rs 228.1, down 2.02% from the previous close. Market cap was Rs 26,420.6 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Piramal Pharma Share Price stands at Rs 228.10 as of 29 October 2026 at 12:52 PM IST, down 2.02% from the previous close of Rs 232.80, after the stock touched a fresh 52-week high of Rs 239.40 today. The company&#8217;s market capitalisation is Rs 26,420.60 crore.<\/p>\n<p style=\"margin-top:0!important;\">This Piramal Pharma Stock News update covers what happened today, what the latest Univest figures show on valuation and returns, and how the stock compares with its industry and listed peers. According to Univest data, the price event is confirmed, but no company-specific catalyst is established, so the analysis below sticks to price action, fundamentals, benchmarks and peer numbers.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#Piramal_Pharma_Share_Price_Today_Price_Action_Analysis\" title=\"Piramal Pharma Share Price Today: Price Action Analysis\">Piramal Pharma Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#Piramal_Pharma_Ltd_PPLPHARMA_Fundamental_Analysis\" title=\"Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis\">Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#Why_Investors_Are_Watching_Piramal_Pharma\" title=\"Why Investors Are Watching Piramal Pharma\">Why Investors Are Watching Piramal Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#About_Piramal_Pharma\" title=\"About Piramal Pharma\">About Piramal Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#What_is_the_Piramal_Pharma_Share_Price_today\" title=\"What is the Piramal Pharma Share Price today?\">What is the Piramal Pharma Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#Has_Piramal_Pharma_touched_a_52-week_high_today\" title=\"Has Piramal Pharma touched a 52-week high today?\">Has Piramal Pharma touched a 52-week high today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#How_has_the_Piramal_Pharma_stock_moved_today\" title=\"How has the Piramal Pharma stock moved today?\">How has the Piramal Pharma stock moved today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#What_is_the_Piramal_Pharma_market_cap\" title=\"What is the Piramal Pharma market cap?\">What is the Piramal Pharma market cap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#What_is_the_Piramal_Pharma_PB_ratio_compared_with_the_industry\" title=\"What is the Piramal Pharma P\/B ratio compared with the industry?\">What is the Piramal Pharma P\/B ratio compared with the industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#What_are_the_Piramal_Pharma_ROE_and_ROCE\" title=\"What are the Piramal Pharma ROE and ROCE?\">What are the Piramal Pharma ROE and ROCE?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#What_are_the_Piramal_Pharma_EPS_book_value_and_dividend_yield\" title=\"What are the Piramal Pharma EPS, book value and dividend yield?\">What are the Piramal Pharma EPS, book value and dividend yield?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#How_does_Piramal_Pharma_compare_with_its_listed_peers\" title=\"How does Piramal Pharma compare with its listed peers?\">How does Piramal Pharma compare with its listed peers?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-ltd-share-price-52-week-high-today-2026\/#Track_Piramal_Pharma_Share_Price_on_Univest\" title=\"Track Piramal Pharma Share Price on Univest\">Track Piramal Pharma Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Piramal Pharma Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 228.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 232.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -4.7 (-2.02%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 231.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 239.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 225.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 26,420.6 crore<\/td>\n<\/tr>\n<\/table>\n<p>Readers following Piramal Pharma Share Price Today in the Indian stock market can monitor whether the stock returns toward its 52-week high of Rs 239.40, how its P\/B ratio of 3.81 compares with the industry median of 2.74, and how future filings compare with the Sep 2026 revenue of Rs 2,617.06 crore.<\/p>\n<p>Piramal Pharma Ltd. (PPLPHARMA) traded at Rs 228.1 versus the previous close of Rs 232.8, a fall of 2.02%. The stock opened at Rs 231.4, reached a high of Rs 239.4 and touched a low of Rs 225.75.<\/p>\n<p>Piramal Pharma Share Price Today is Rs 228.10, a fall of Rs 4.70 or 2.02% from the previous close of Rs 232.80. The stock touched a fresh 52-week high of Rs 239.40 and now trades Rs 11.30 below that level, which keeps the Piramal Pharma 52 Week High event in focus.<\/p>\n<p>The stock opened at Rs 231.40, Rs 1.40 below the previous close, and touched a low of Rs 225.75 during the day, Rs 7.05 under that close. From there, Piramal Pharma moved between Rs 225.75 and Rs 239.40, a range of Rs 13.65, and it now trades Rs 3.30 below its opening level.<\/p>\n<p>Because the 52-week high and the day high are the same price, this one-year high was set earlier today. The Piramal Pharma Share Price Update therefore describes a stock that opened below its previous close, reached a yearly peak and now trades Rs 2.35 above the day low and below the previous close. With the price event confirmed, the next question is whether valuation and returns add context.<\/p>\n<p>For readers comparing Piramal Pharma Share Price against earlier levels, the useful reference points are the previous close of Rs 232.80, the opening price of Rs 231.40 and the 52-week high of Rs 239.40. The gap between the previous close and the current price is Rs 4.70, which is the 2.02% move reported by Univest. These stock updates are based on figures as of 12:52 PM IST and can change as trading continues through the day.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_Ltd_PPLPHARMA_Fundamental_Analysis\"><\/span><strong>Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 26,420.6 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.81x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-4.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -1.57<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 61.18<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Piramal Pharma Ltd. (PPLPHARMA) fundamental metrics show P\/B 3.81x, ROE -4.04%, ROCE 1.24%. Read together, these ratios describe the company&#8217;s position rather than a recommendation.<\/p>\n<p>Piramal Pharma Ltd. has a market capitalisation of Rs 26,420.6 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/B at 3.81x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -4.04% and ROCE of 1.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -1.57, book value per share of Rs 61.18, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 31.57x, median ROE of 11.23%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.57x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">46.23x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.21x to 598.47x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.81x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-4.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.23%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 26,420.6 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 711.9 crore<\/td>\n<\/tr>\n<\/table>\n<p>Piramal Pharma Ltd. (PPLPHARMA) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Piramal Pharma Ltd. (PPLPHARMA) has a ROE of -4.04%, which is below the benchmark median of 11.23%, a difference of -135.98%. Piramal Pharma Ltd. (PPLPHARMA) has a ROCE of 1.24%, which is below the benchmark median of 13.1%, a difference of -90.53%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/rubicon\/rubicon-research-limited-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>RUBICON RESEARCH LIMITED<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">RUBICON<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25,078.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">89.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.22<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Neuland Laboratories Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">NEULANDLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24,751.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">51.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/wockpharma\/wockhardt-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Wockhardt Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">WOCKPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">30,629.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.79<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/granules\/granules-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Granules India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GRANULES<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22,745.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.74<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/acutaas\/ami-organics-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>AMI Organics Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ACUTAAS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31,066.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">69.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.42<\/td>\n<\/tr>\n<\/table>\n<p>Its ROE of -4.04% compares with a peer median of 21.43% across the companies shown in the table. ROCE stood at 1.24% versus the displayed peer median of 27.5%, providing a capital-efficiency comparison. Piramal Pharma Ltd. (PPLPHARMA) has a market capitalisation of Rs 26,420.6 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Piramal_Pharma\"><\/span><strong>Why Investors Are Watching Piramal Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Piramal Pharma Share Price is Rs 228.10, down 2.02% from the previous close of Rs 232.80.<\/li>\n<li>The stock touched a fresh 52-week high of Rs 239.40 today, and the day high equals that level.<\/li>\n<li>The P\/B ratio of 3.81 compares with an industry median of 2.74 across 195 companies.<\/li>\n<li>ROE of -4.04% and ROCE of 1.24% are below the industry medians of 11.23% and 13.10%.<\/li>\n<li>Revenue for the Sep 2026 quarter is Rs 2,617.06 crore, and market capitalisation is Rs 26,420.60 crore.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Piramal_Pharma\"><\/span><strong>About Piramal Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Piramal Pharma Ltd. is classified under the Healthcare sector and the Pharmaceuticals &#038; Drugs industry in the latest Univest figures. The stock is quoted under the symbol PPLPHARMA, and its latest quarterly revenue label is Sep 2026. Market capitalisation, valuation multiples and peer figures for the company are covered in the sections above.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Piramal_Pharma_Share_Price_today\"><\/span><strong>What is the Piramal Pharma Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Piramal Pharma Share Price is Rs 228.10 as of 29 October 2026 at 12:52 PM IST, down Rs 4.70 or 2.02% from the previous close of Rs 232.80, within a day range of Rs 225.75 to Rs 239.40.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Has_Piramal_Pharma_touched_a_52-week_high_today\"><\/span><strong>Has Piramal Pharma touched a 52-week high today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. According to latest Univest data, Piramal Pharma touched a fresh 52-week high of Rs 239.40 today. The stock now trades at Rs 228.10, which is Rs 11.30 below that one-year high, and the day high matches it.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_the_Piramal_Pharma_stock_moved_today\"><\/span><strong>How has the Piramal Pharma stock moved today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Piramal Pharma stock is down 2.02%, a fall of Rs 4.70, from the previous close of Rs 232.80. It opened at Rs 231.40, touched a low of Rs 225.75 and then reached Rs 239.40.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Piramal_Pharma_market_cap\"><\/span><strong>What is the Piramal Pharma market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Piramal Pharma Market Cap is Rs 26,420.60 crore according to the latest Univest figures. The Pharmaceuticals &amp; Drugs benchmark of 198 companies has a median market capitalisation of Rs 711.90 crore and an average of Rs 13,753.79 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Piramal_Pharma_PB_ratio_compared_with_the_industry\"><\/span><strong>What is the Piramal Pharma P\/B ratio compared with the industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Piramal Pharma has a P\/B ratio of 3.81 against an industry median of 2.74 and an average of 4.02. That places the P\/B 39.05% above the median across the 195 companies with a reported P\/B.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_Piramal_Pharma_ROE_and_ROCE\"><\/span><strong>What are the Piramal Pharma ROE and ROCE?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Piramal Pharma reports ROE of -4.04% and ROCE of 1.24%. The industry medians are 11.23% for ROE and 13.10% for ROCE, so both return ratios sit below the Pharmaceuticals &amp; Drugs benchmark across 197 companies.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_Piramal_Pharma_EPS_book_value_and_dividend_yield\"><\/span><strong>What are the Piramal Pharma EPS, book value and dividend yield?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Piramal Pharma reports EPS of Rs -1.57 and book value of Rs 61.18 per share, with a P\/B ratio of 3.81. Dividend yield is 0%, a historical measure of payout relative to the current price, not a promise.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Piramal_Pharma_compare_with_its_listed_peers\"><\/span><strong>How does Piramal Pharma compare with its listed peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Piramal Pharma has a P\/B of 3.81, below all five listed peers shown, which range from 4.68 to 19.30. Its ROE of -4.04% and ROCE of 1.24% are also below each peer, while its market cap is above three of them.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Piramal Pharma Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma Share Price is Rs 228.10 as of 29 October 2026 at 12:52 PM IST, down Rs 4.70 or 2.02% from the previous close of Rs 232.80, within a day range of Rs 225.75 to Rs 239.40.\"}},{\"@type\":\"Question\",\"name\":\"Has Piramal Pharma touched a 52-week high today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. According to latest Univest data, Piramal Pharma touched a fresh 52-week high of Rs 239.40 today. The stock now trades at Rs 228.10, which is Rs 11.30 below that one-year high, and the day high matches it.\"}},{\"@type\":\"Question\",\"name\":\"How has the Piramal Pharma stock moved today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Piramal Pharma stock is down 2.02%, a fall of Rs 4.70, from the previous close of Rs 232.80. It opened at Rs 231.40, touched a low of Rs 225.75 and then reached Rs 239.40.\"}},{\"@type\":\"Question\",\"name\":\"What is the Piramal Pharma market cap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma Market Cap is Rs 26,420.60 crore according to the latest Univest figures. The Pharmaceuticals & Drugs benchmark of 198 companies has a median market capitalisation of Rs 711.90 crore and an average of Rs 13,753.79 crore.\"}},{\"@type\":\"Question\",\"name\":\"What is the Piramal Pharma P\/B ratio compared with the industry?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma has a P\/B ratio of 3.81 against an industry median of 2.74 and an average of 4.02. That places the P\/B 39.05% above the median across the 195 companies with a reported P\/B.\"}},{\"@type\":\"Question\",\"name\":\"What are the Piramal Pharma ROE and ROCE?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma reports ROE of -4.04% and ROCE of 1.24%. The industry medians are 11.23% for ROE and 13.10% for ROCE, so both return ratios sit below the Pharmaceuticals & Drugs benchmark across 197 companies.\"}},{\"@type\":\"Question\",\"name\":\"What are the Piramal Pharma EPS, book value and dividend yield?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma reports EPS of Rs -1.57 and book value of Rs 61.18 per share, with a P\/B ratio of 3.81. Dividend yield is 0%, a historical measure of payout relative to the current price, not a promise.\"}},{\"@type\":\"Question\",\"name\":\"How does Piramal Pharma compare with its listed peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma has a P\/B of 3.81, below all five listed peers shown, which range from 4.68 to 19.30. Its ROE of -4.04% and ROCE of 1.24% are also below each peer, while its market cap is above three of them.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Piramal_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Piramal Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/pplpharma\/piramal-pharma-ltd-share-price-today\">Piramal Pharma Ltd. (PPLPHARMA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Users can track the live Piramal Pharma Share Price, fundamental ratios, 52-week levels and market insights on Univest. The Piramal Pharma Share Price Live page brings price, valuation and peer figures together, so readers can compare today&#8217;s 52-week high of Rs 239.40 with the latest numbers as they update through the day.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Piramal Pharma Ltd. Share Price hit a fresh 52-week high of Rs 239.40 today and is trading at Rs 228.10, down 2.02% on the day. Market cap stands at Rs 26,420.60 crore.<\/p>\n","protected":false},"author":35,"featured_media":332011,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-332012","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["332011"],"rank_math_title":["Piramal Pharma Share Price Hits 52-Week High of Rs 239.40"],"rank_math_description":["Piramal Pharma Share Price touched a fresh 52-week high of Rs 239.40 and trades 2.02% lower. Read the P\/B, ROE, ROCE, sector and peer analysis here."],"rank_math_focus_keyword":["Piramal Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/Piramal_Pharma_PPLPHARMA_Share_Price_Touches_Fresh_52_Week_High_of_Rs_23940_Trades_202_Lower_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/332012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=332012"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/332012\/revisions"}],"predecessor-version":[{"id":332013,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/332012\/revisions\/332013"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/332011"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=332012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=332012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=332012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}